Cambre supported a leading producer of smoking cessation therapies in engaging with Members of the European Parliament and media. With our support, the client managed to influence the legislative process and as a result tighter restrictions on electronic cigarettes were implemented.
During the negotiations for the Tobacco Products Directive, there were differing views on whether electronic cigarettes should be regulated as medicinal products, like other nicotine-containing products, or as consumer goods.
Cambre was asked by a leading producer of smoking cessation therapies to propose and lead an engagement programme with Members of the European Parliament and the media to communicate the reasons opposing the creation of a two-tier regulatory system for nicotine-containing products.
The outcome of the legislative process was tighter restrictions on electronic cigarettes and a more limited range permitted to be sold as consumer products.